$HBIO
HARVARD BIOSCIENCE INC

2020 Q4 Form 10-Q Financial Statement

#000117184320007747 Filed on November 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $30.98M $24.04M $27.42M
YoY Change 0.03% -12.33% -4.25%
Cost Of Revenue $13.28M $10.54M $12.44M
YoY Change -3.33% -15.25% -2.96%
Gross Profit $17.71M $13.50M $14.98M
YoY Change 2.76% -9.91% -5.3%
Gross Profit Margin 57.17% 56.14% 54.63%
Selling, General & Admin $11.15M $9.987M $11.90M
YoY Change 0.09% -16.06% 11.45%
% of Gross Profit 62.96% 74.01% 79.43%
Research & Development $2.350M $1.949M $2.564M
YoY Change -11.32% -23.99% -7.87%
% of Gross Profit 13.27% 14.44% 17.12%
Depreciation & Amortization $1.920M $1.850M $1.940M
YoY Change -1.54% -4.64% 2.65%
% of Gross Profit 10.84% 13.71% 12.95%
Operating Expenses $14.94M $13.31M $16.34M
YoY Change -4.24% -18.55% 9.49%
Operating Profit $2.770M $182.0K -$1.365M
YoY Change 69.63% -113.33% -253.37%
Interest Expense -$1.090M -$1.205M $1.348M
YoY Change -16.79% -189.39% -7.54%
% of Operating Profit -39.35% -662.09%
Other Income/Expense, Net -$330.0K -$1.597M -$1.309M
YoY Change -78.5% 22.0% -27.2%
Pretax Income -$550.0K -$1.415M -$2.674M
YoY Change -661.22% -47.08% 194.49%
Income Tax $70.00K -$300.0K -$100.0K
% Of Pretax Income
Net Earnings -$620.0K -$1.098M -$2.620M
YoY Change -212.73% -58.09% 923.44%
Net Earnings / Revenue -2.0% -4.57% -9.56%
Basic Earnings Per Share -$0.07
Diluted Earnings Per Share -$15.92K -$28.26K -$0.07
COMMON SHARES
Basic Shares Outstanding 38.98M 38.92K 38.04M
Diluted Shares Outstanding 38.92K 38.04M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.300M $2.800M $6.800M
YoY Change 0.0% -58.82% 1.49%
Cash & Equivalents $8.317M $2.806M $6.845M
Short-Term Investments
Other Short-Term Assets $3.355M $4.146M
YoY Change 35.72%
Inventory $22.26M $22.69M $23.89M
Prepaid Expenses
Receivables $17.77M $13.88M $17.09M
Other Receivables $3.300M $4.100M $4.500M
Total Short-Term Assets $51.70M $43.52M $52.30M
YoY Change -3.49% -16.79% -4.04%
LONG-TERM ASSETS
Property, Plant & Equipment $3.960M $4.309M $13.70M
YoY Change -17.09% -68.55% 153.7%
Goodwill $58.59M $57.65M $56.64M
YoY Change 2.11% 1.78% 1.5%
Intangibles $33.15M $34.32M
YoY Change -13.68%
Long-Term Investments
YoY Change
Other Assets $1.092M $1.896M $300.0K
YoY Change -51.96% 532.0% -85.0%
Total Long-Term Assets $104.6M $106.1M $110.5M
YoY Change -6.06% -3.99% 0.0%
TOTAL ASSETS
Total Short-Term Assets $51.70M $43.52M $52.30M
Total Long-Term Assets $104.6M $106.1M $110.5M
Total Assets $156.3M $149.6M $162.8M
YoY Change -5.23% -8.1% -1.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.972M $5.990M $5.266M
YoY Change 11.86% 13.75% -2.34%
Accrued Expenses $7.600M $6.600M $9.900M
YoY Change 24.77% -33.33% 57.14%
Deferred Revenue $3.771M $3.559M
YoY Change -4.51%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $3.200M $2.600M
YoY Change -37.5% 23.08% 44.44%
Total Short-Term Liabilities $21.05M $21.25M $21.70M
YoY Change -16.83% -2.08% 12.44%
LONG-TERM LIABILITIES
Long-Term Debt $46.29M $40.67M $51.70M
YoY Change -1.34% -21.34% -12.67%
Other Long-Term Liabilities $2.854M $932.0K $10.00M
YoY Change 281.04% -90.68% 185.71%
Total Long-Term Liabilities $49.14M $41.60M $61.70M
YoY Change 3.09% -32.58% -1.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.05M $21.25M $21.70M
Total Long-Term Liabilities $49.14M $41.60M $61.70M
Total Liabilities $79.57M $72.45M $85.70M
YoY Change -4.33% -15.46% 1.9%
SHAREHOLDERS EQUITY
Retained Earnings -$132.4M -$131.8M
YoY Change 6.27%
Common Stock $232.8M $231.6M
YoY Change 1.38%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.67M
YoY Change
Treasury Stock Shares $7.746M $7.746M 7.746M shares
Shareholders Equity $76.68M $77.17M $77.10M
YoY Change
Total Liabilities & Shareholders Equity $156.3M $149.6M $162.8M
YoY Change -5.23% -8.1% -1.33%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$620.0K -$1.098M -$2.620M
YoY Change -212.73% -58.09% 923.44%
Depreciation, Depletion And Amortization $1.920M $1.850M $1.940M
YoY Change -1.54% -4.64% 2.65%
Cash From Operating Activities $2.490M $1.600M $3.160M
YoY Change 12.16% -49.37% -319.44%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K -$570.0K -$360.0K
YoY Change -86.05% 58.33% 38.46%
Acquisitions
YoY Change
Other Investing Activities -$250.0K $0.00 $0.00
YoY Change 733.33%
Cash From Investing Activities -$310.0K -$570.0K -$360.0K
YoY Change -32.61% 58.33% 38.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.350M -950.0K -660.0K
YoY Change -897.62% 43.94% -124.44%
NET CHANGE
Cash From Operating Activities 2.490M 1.600M 3.160M
Cash From Investing Activities -310.0K -570.0K -360.0K
Cash From Financing Activities 3.350M -950.0K -660.0K
Net Change In Cash 5.530M 80.00K 2.140M
YoY Change 312.69% -96.26% 114.0%
FREE CASH FLOW
Cash From Operating Activities $2.490M $1.600M $3.160M
Capital Expenditures -$60.00K -$570.0K -$360.0K
Free Cash Flow $2.550M $2.170M $3.520M
YoY Change -3.77% -38.35% -398.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38975510
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.01
CY2019Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46719632
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45933715
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38974125
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38188208
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4300000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.21
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2806000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8335000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13879000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20704000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
22689000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
22061000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4146000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2472000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
43520000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
53572000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4309000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4776000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7927000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8463000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
57647000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
57381000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
34315000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
38405000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1896000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2273000 USD
CY2020Q3 us-gaap Assets
Assets
149614000 USD
CY2019Q4 us-gaap Assets
Assets
164870000 USD
CY2020Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
2807000 USD
CY2019Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
6900000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2190000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2424000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5990000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5339000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3559000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3949000 USD
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
749000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
609000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5953000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6091000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
21248000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25312000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40669000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46917000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1906000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1974000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7692000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8224000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
932000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
749000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
72447000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
83176000 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
438000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
438000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
231142000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
229189000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131771000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124576000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11974000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12689000 USD
CY2020Q3 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2019Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
77167000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
81694000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
149614000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
164870000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24037000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27418000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85204000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10542000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12439000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30783000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38116000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
13495000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
14979000 USD
us-gaap Gross Profit
GrossProfit
40333000 USD
us-gaap Gross Profit
GrossProfit
47088000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4588000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5294000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14446000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17370000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5399000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6604000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17828000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17215000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1949000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2564000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6336000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8070000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1377000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1422000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4258000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4289000 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
460000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1401000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
13313000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
16344000 USD
us-gaap Operating Expenses
OperatingExpenses
42868000 USD
us-gaap Operating Expenses
OperatingExpenses
48345000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
182000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1365000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2535000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1257000 USD
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1205000 USD
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1348000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3737000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4129000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-392000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-472000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-214000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1597000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1309000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4209000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4343000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1415000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2674000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6744000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5600000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-317000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
451000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-363000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1098000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2620000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7195000 USD
us-gaap Net Income Loss
NetIncomeLoss
-5237000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38920000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38036000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38540000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37764000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1098000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2620000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7195000 USD
us-gaap Net Income Loss
NetIncomeLoss
-5237000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1638000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1495000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
681000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1686000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-1000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-78000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-228000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-572000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-93000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-37000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-262000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-73000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
92000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-41000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
34000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-499000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1730000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1536000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
715000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2185000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
632000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4156000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6480000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7422000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
76068000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
620000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1079000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1098000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1730000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
77167000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
80330000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
70000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
128000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
987000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2620000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1536000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
77103000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
81694000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
168000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
882000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2641000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7195000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
715000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
77167000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
82724000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
159000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
551000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2193000 USD
us-gaap Net Income Loss
NetIncomeLoss
-5237000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2185000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
77103000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7195000 USD
us-gaap Net Income Loss
NetIncomeLoss
-5237000 USD
us-gaap Depreciation
Depreciation
1453000 USD
us-gaap Depreciation
Depreciation
1497000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1401000 USD
hbio Amortization Of Intangible Assets Including Amounts Related To Discontinued Operation
AmortizationOfIntangibleAssetsIncludingAmountsRelatedToDiscontinuedOperation
4258000 USD
hbio Amortization Of Intangible Assets Including Amounts Related To Discontinued Operation
AmortizationOfIntangibleAssetsIncludingAmountsRelatedToDiscontinuedOperation
4289000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
295000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
287000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2641000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2193000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
24000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
394000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-41000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6805000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3805000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
511000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-635000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
878000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
147000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
665000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2059000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
102000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-591000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-181000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
180000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-380000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-255000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-262000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-608000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6841000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5825000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1088000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
778000 USD
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 USD
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
1020000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
15000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1088000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
227000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
9615000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
4300000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
20251000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
11103000 USD
hbio Net Taxes Paid Net Proceeds From Issuance Of Common Stock
NetTaxesPaidNetProceedsFromIssuanceOfCommonStock
-688000 USD
hbio Net Taxes Paid Net Proceeds From Issuance Of Common Stock
NetTaxesPaidNetProceedsFromIssuanceOfCommonStock
-392000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11324000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7195000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
42000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-185000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5529000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1328000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8335000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8173000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2806000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6845000 USD
us-gaap Interest Paid Net
InterestPaidNet
3795000 USD
us-gaap Interest Paid Net
InterestPaidNet
4226000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
410000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
411000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;"><tbody><tr><td style="vertical-align: top; width: 43px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">2.</em></b></p> </td><td style="vertical-align: top; width: 1711px;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Recently Issued Accounting Pronouncements</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;"><i>Accounting Pronouncements to be Adopted</i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">In <em style="font: inherit;"> September 2016, </em>the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <em style="font: inherit;">No.</em> <em style="font: inherit;">2016</em>-<em style="font: inherit;">13,</em> <i>Financial Instruments—Credit Losses (Topic <em style="font: inherit;">326</em>): Measurement of Credit Losses on Financial</i> <i>Instruments (ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em>), </i>which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred<i> </i>losses to estimate credit losses on certain types of financial instruments, including trade receivables. This <em style="font: inherit;"> may </em>result in the earlier recognition of allowances for losses. The FASB issued several ASUs after ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em> to clarify implementation guidance and to provide transition relief for certain entities. ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em> is effective for the Company for fiscal years beginning after <em style="font: inherit;"> December 15, 2022, </em>with early adoption permitted. The Company is evaluating the impact that adopting ASU <em style="font: inherit;">2016</em>-<em style="font: inherit;">13</em> and related amendments will have on its consolidated financial position, results of operations and cash flows.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">In <em style="font: inherit;"> August 2018, </em>the FASB issued ASU <em style="font: inherit;">No.</em> <em style="font: inherit;">2018</em>-<em style="font: inherit;">14,</em> <i>Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans</i><i> </i>(ASU <em style="font: inherit;">2018</em>-<em style="font: inherit;">14</em>), which amends ASC <em style="font: inherit;">715</em> to add, remove and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU is effective for public entities for fiscal years ending after <em style="font: inherit;"> December 15, 2020, </em>with early adoption permitted. The Company is evaluating the effect of adopting this new accounting guidance but does <em style="font: inherit;">not</em> expect adoption will have a material impact on the disclosure in the Company’s Consolidated Financial Statements.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:26.4pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">In <em style="font: inherit;"> December 2019, </em>the FASB issued ASU <em style="font: inherit;">2019</em>-<em style="font: inherit;">12,</em> <i>Income Taxes (Topic <em style="font: inherit;">740</em>): Simplifying the Accounting for Income Taxes</i> (ASU <em style="font: inherit;">2019</em>-<em style="font: inherit;">12</em>), which enhances and simplifies various aspects of the income tax accounting guidance related to intra-period tax allocation, interim period accounting for enacted changes in tax law, and the year-to-date loss limitation in interim period tax accounting. ASU <em style="font: inherit;">2019</em>-<em style="font: inherit;">12</em> also amends other aspects of the guidance to reduce complexity in certain areas. ASU <em style="font: inherit;">2019</em>-<em style="font: inherit;">12</em> is effective for the Company on <em style="font: inherit;"> January 1, 2021. </em>Early adoption is permitted. The Company is evaluating the effect of adopting this new accounting guidance but does <em style="font: inherit;">not</em> expect adoption will have a material impact on the Company’s Consolidated Financial Statements.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:26.4pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p>
CY2019Q4 us-gaap Goodwill
Goodwill
57381000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
266000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
57647000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
68358000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
34287000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34071000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
67023000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
29753000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
37270000 USD
CY2020Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
244000 USD
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1135000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
34315000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
38405000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4300000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1676000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5703000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5672000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5569000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5267000 USD
CY2020Q3 hbio Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
10184000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34071000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5311000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5561000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3897000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3153000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13481000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13347000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
22689000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
22061000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2218000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2554000 USD
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
594000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
395000 USD
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
184000 USD
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
252000 USD
CY2020Q3 hbio Customer Related Costs
CustomerRelatedCosts
1038000 USD
CY2019Q4 hbio Customer Related Costs
CustomerRelatedCosts
963000 USD
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
376000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
425000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1543000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1502000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5953000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6091000 USD
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
319000 USD
CY2019Q3 us-gaap Restructuring Charges
RestructuringCharges
914000 USD
us-gaap Restructuring Charges
RestructuringCharges
1895000 USD
us-gaap Restructuring Charges
RestructuringCharges
914000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
368000 USD
us-gaap Restructuring Charges
RestructuringCharges
1895000 USD
us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
168000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
1487000 USD
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
608000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1400000 USD
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
600000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8463000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
565000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
523000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1647000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1561000 USD
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
46000 USD
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
29000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
131000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
156000 USD
CY2020Q3 us-gaap Sublease Income
SubleaseIncome
26000 USD
CY2019Q3 us-gaap Sublease Income
SubleaseIncome
104000 USD
us-gaap Sublease Income
SubleaseIncome
158000 USD
us-gaap Sublease Income
SubleaseIncome
309000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
585000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
448000 USD
us-gaap Lease Cost
LeaseCost
1620000 USD
us-gaap Lease Cost
LeaseCost
1408000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
2041000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7927000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1815000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
401000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2190000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2424000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7692000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8224000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9882000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10648000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M6D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y1M6D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.092 pure
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.092 pure
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2198000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1999000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1944000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1897000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1044000 USD
CY2020Q3 hbio Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
5086000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14168000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4286000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9882000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3700000
CY2019Q2 hbio Fungible Share Ratio For Deferred Stock Awards
FungibleShareRatioForDeferredStockAwards
1.79 pure
CY2020Q2 hbio Fungible Share Ratio For Deferred Stock Awards
FungibleShareRatioForDeferredStockAwards
1.49 pure
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3288084
hbio Restricted Stock Units Ratio
RestrictedStockUnitsRatio
1.49 pure
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2266122
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
894154
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.61
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9994
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
253419
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.43
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2896863
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.56
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46917000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5400000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1079000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
987000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2641000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2193000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.21
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38920041
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38036261
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38539703
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37764489
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38920041
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38036261
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38539703
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37764489
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5473292
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4055076
CY2020Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
885000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1180000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
43476000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
53817000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3200000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3200000 USD
CY2020Q3 hbio Excess Cash Sweep
ExcessCashSweep
-0 USD
CY2019Q4 hbio Excess Cash Sweep
ExcessCashSweep
4093000 USD
CY2020Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
393000 USD
CY2019Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
393000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40669000 USD
hbio Accounts Receivable Allowance For Credit Loss Effect Of Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossEffectOfForeignCurrencyTranslation
-8000 USD
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
-300000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24037000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27418000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85204000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3600000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3600000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3652000 USD
CY2020Q3 hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
1324000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1428000 USD
CY2020Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
11000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3559000 USD
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3532000 USD
CY2019Q3 hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
781000 USD
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
779000 USD
CY2019Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
16000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3550000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3949000 USD
hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
2498000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2883000 USD
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-5000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3559000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
325000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
332000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
24000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3820000 USD
hbio Contract With Customer Liability Deferred Revenue
ContractWithCustomerLiabilityDeferredRevenue
2158000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2444000 USD
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
16000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3550000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
394000 USD
hbio Accounts Receivable Allowance For Credit Loss Chargeoffs And Other Reoveries
AccountsReceivableAllowanceForCreditLossChargeoffsAndOtherReoveries
60000 USD
hbio Accounts Receivable Allowance For Credit Loss Chargeoffs And Other Reoveries
AccountsReceivableAllowanceForCreditLossChargeoffsAndOtherReoveries
354000 USD
hbio Accounts Receivable Allowance For Credit Loss Effect Of Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossEffectOfForeignCurrencyTranslation
4000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
293000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
364000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.224 pure
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.020 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.067 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.065 pure

Files In Submission

Name View Source Status
0001171843-20-007747-index-headers.html Edgar Link pending
0001171843-20-007747-index.html Edgar Link pending
0001171843-20-007747.txt Edgar Link pending
0001171843-20-007747-xbrl.zip Edgar Link pending
ex_210777.htm Edgar Link pending
ex_210778.htm Edgar Link pending
ex_210779.htm Edgar Link pending
ex_210780.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hbio-20200930.xsd Edgar Link pending
hbio-20200930_cal.xml Edgar Link unprocessable
hbio-20200930_def.xml Edgar Link unprocessable
hbio-20200930_lab.xml Edgar Link unprocessable
hbio-20200930_pre.xml Edgar Link unprocessable
hboi20200930_10q.htm Edgar Link pending
hboi20200930_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending